SABS Stock Summary and Trading Ideas (Sab Biotherapeutics | NASDAQ:SABS)

SAB Biotherapeutics Inc is a clinical-stage biopharmaceutical company focused on developing multi-specific, high-potency, human immunoglobulin G (hIgG) to treat and prevent immune and autoimmune disorders. The company's lead product candidate, SAB-142, targets autoimmune Type 1 Diabetes (T1D) with a disease-modifying therapeutic approach that aims to change the T1D treatment paradigm by delaying onset and potentially preventing disease progression of Stage 3 T1D patients. It is focused on developing product candidates for disease targets where a differentiated approach has the greatest potential to be either first-in-class against novel targets against complex targets to treat diseases, including type 1 diabetes (T1D) and other autoimmune disorders.

What symbol and exchange does Sab Biotherapeutics shares trade?

Sab Biotherapeutics trades on the NASDAQ stock market under the symbol SABS.

What is Sab Biotherapeutics stock price doing today?

As of June 12, 2026, SABS stock price declined to $3.33 with 338,580 million shares trading.

What is Sab Biotherapeutics's Beta?

SABS has a beta of 0.13, meaning it tends to be less sensitive to market movements. SABS has a correlation of 0.00 to the broad based SPY ETF.

How much is Sab Biotherapeutics worth?

SABS has a market cap of $254.63 million. This is considered a Small Cap stock.

What is the highest and lowest price Sab Biotherapeutics traded in the last 3 year period?

In the last 3 years, SABS traded as high as $10.50 and as low as $1.00.

What are the top ETFs holding Sab Biotherapeutics?

The top ETF exchange traded funds that SABS belongs to (by Net Assets): VTI, VXF, AVSC.

Is Sab Biotherapeutics (SABS) a good investment?

SABS has outperformed the market in the last year with a return of +81.9%, while the SPY ETF gained +24.1%. However, in the most recent history, SABS shares have underperformed the stock market with its stock returning -27.5% in the last 3 month period and -7.5% for the last 2 week period, while SPY has returned +11.6% and -1.9%, respectively.

What are the support and resistance levels for Sab Biotherapeutics (SABS)?

SABS support price is $3.25 and resistance is $3.51 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that SABS shares will trade within this expected range on the day.